Literature DB >> 7753869

Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene.

S P Kwan1, T L Hagemann, B E Radtke, R M Blaese, F S Rosen.   

Abstract

The Wiskott-Aldrich syndrome (WAS) is an X-chromosome-linked recessive disease characterized by eczema, thrombocytopenia, and immunodeficiency. The disease gene has been localized to the proximal short arm of the X chromosome and recently isolated through positional cloning. The function of the encoded protein remains undetermined. In this study we have characterized mutations in 12 unrelated patients to confirm the identity of the disease gene. We have also revised the coding sequence and genomic structure for the WAS gene. To analyze further the transmittance of the disease gene, we have characterized a polymorphic microsatellite at the DXS6940 locus within 30 kb of the gene and demonstrate the inheritance of the affected alleles in families with a history of WAS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753869      PMCID: PMC42013          DOI: 10.1073/pnas.92.10.4706

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Yeast artificial chromosome libraries containing large inserts from mouse and human DNA.

Authors:  Z Larin; A P Monaco; H Lehrach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Direct selection: a method for the isolation of cDNAs encoded by large genomic regions.

Authors:  M Lovett; J Kere; L M Hinton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome.

Authors:  G Wengler; J B Gorlin; J M Williamson; F S Rosen; D H Bing
Journal:  Blood       Date:  1995-05-01       Impact factor: 22.113

4.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome.

Authors:  M Peacocke; K A Siminovitch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Physical mapping in a YAC contig of 11 markers on the human X chromosome in Xp11.23.

Authors:  T Hagemann; R Surosky; A P Monaco; H Lehrach; F S Rosen; S P Kwan
Journal:  Genomics       Date:  1994-05-01       Impact factor: 5.736

7.  Primary immunodeficiency diseases. Report prepared for the WHO by a scientific group on immunodeficiency.

Authors: 
Journal:  Clin Immunol Immunopathol       Date:  1983-09

8.  Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome.

Authors:  D Kenney; L Cairns; E Remold-O'Donnell; J Peterson; F S Rosen; R Parkman
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

9.  Mapping the gene encoding the human erythroid transcriptional factor NFE1-GF1 to Xp11.23.

Authors:  A Caiulo; S Nicolis; P Bianchi; O Zuffardi; B Bardoni; P Maraschio; S Ottolenghi; G Camerino; B Giglioni
Journal:  Hum Genet       Date:  1991-02       Impact factor: 4.132

10.  T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome.

Authors:  I J Molina; D M Kenney; F S Rosen; E Remold-O'Donnell
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  19 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

3.  Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.

Authors:  T Wada; S H Schurman; M Otsu; E K Garabedian; H D Ochs; D L Nelson; F Candotti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 4.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells.

Authors:  H Y She; S Rockow; J Tang; R Nishimura; E Y Skolnik; M Chen; B Margolis; W Li
Journal:  Mol Biol Cell       Date:  1997-09       Impact factor: 4.138

6.  N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases.

Authors:  H Miki; K Miura; T Takenawa
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

7.  Studies of the expression of the Wiskott-Aldrich syndrome protein.

Authors:  D M Stewart; S Treiber-Held; C C Kurman; F Facchetti; L D Notarangelo; D L Nelson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42.

Authors:  R Kolluri; K F Tolias; C L Carpenter; F S Rosen; T Kirchhausen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.

Authors:  Hervé Falet; Michael P Marchetti; Karin M Hoffmeister; Michel J Massaad; Raif S Geha; John H Hartwig
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

10.  Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains.

Authors:  S M Ahern-Djamali; A R Comer; C Bachmann; A S Kastenmeier; S K Reddy; M C Beckerle; U Walter; F M Hoffmann
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.